Safety and efficacy of high-dose G-CSF (24 μg/kg) alone for PBSC mobilization in children

Bone Marrow Transplantation

Volumn 30, Issue 12, 2002, Pages 987-988

  Perez Duenas B ^a   Alcorta, I ^a   Estella, J ^a   Rives, S ^a   Toll, T ^a   Tuset, E ^a  

^a HOSPITAL SANT JOAN DE DÉU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; APHERESIS; BONE MARROW BIOPSY; BRAIN STEM TUMOR; BURKITT LYMPHOMA; CELL COUNT; CENTRAL VEIN; CHILD; CHILD CARE; CLINICAL ARTICLE; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EWING SARCOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; LEUKAPHERESIS; LEUKOCYTOSIS; MEDULLOBLASTOMA; OSTEOSARCOMA; PERIPHERAL BLOOD STEM CELL; PINEAL BODY TUMOR; PRIORITY JOURNAL; STEM CELL MOBILIZATION; THROMBOCYTOPENIA; VASCULAR ACCESS;

ADOLESCENT; BLOOD CELL COUNT; CHILD; CHILD, PRESCHOOL; DRUG EVALUATION; FEMALE; FILGRASTIM; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; LEUKAPHERESIS; MALE; NEOPLASMS; SAFETY; TREATMENT OUTCOME;

EID: 0036957458     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703723     Document Type: Letter

References (4)

1. + immunoselection. J Clin Oncol 1999; 17: 2160-2172.
2. Demirer T, Ayui M, Ozcan M et al. Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony-stimulating factor (rhG-CSF): a randomized evaluation of different doses of rhG-CSF. Br J Haematol 2002; 116: 468-474.
3. Halle P, Kanold J, Rapatel C et al. Granulocyte colony-stimulating factor alone at 20 μg/kg vs 10 μg/kg for peripheral blood stem cell mobilization in children. Pediatr Transplant 2000; 4: 285-288.
4. Kröger N, Renges H, Krüger W et al. A randomized comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogeneic transplantation. Br J Haematol 2000; 111: 761-765.